97.61
Merit Medical Systems Inc (MMSI) 最新ニュース
Merit Medical Systems' (NASDAQ:MMSI) Returns On Capital Are Heading Higher - Yahoo Finance
MMSI Q1 Earnings Call: Tariff Headwinds Offset by Organic Growth and Strong Product Performance - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Merit Medical Systems, Inc. (MMSI) - ACCESS Newswire
We Take A Look At Why Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Has Earned Their Pay Packet - simplywall.st
Health Canada approves Merit Medical Systems’ Wrapsody CIE device - Yahoo
What To Expect From ICU Medical’s (ICUI) Q1 Earnings - Yahoo Finance
Merit Medical Gets Approval From Health Canada for Wrapsody CIE - marketscreener.com
Merit Medical’s WRAPSODY CIE wins Health Canada approval By Investing.com - Investing.com India
Merit Medical’s WRAPSODY CIE wins Health Canada approval - Investing.com Canada
Merit Medical Systems Says Health Canada Approved Wrapsody Cell-Impermeable Endoprosthesis - Nasdaq
Merit Medical (MMSI) Gains Health Canada Approval for Innovative Stent Device | MMSI Stock News - GuruFocus
Merit Medical Announces Health Canada Approval of the WRAPSODY® - GuruFocus
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis - The Manila Times
Merit Medical Systems Announces Approval of WRAPSODY Cell-Impermeable Endoprosthesis in Canada for Hemodialysis Patients - Nasdaq
Breakthrough: Merit Medical's New Hemodialysis Device Shows 70% Success Rate, Receives Health Canada Approval - Stock Titan
Merit Medical reports positive WAVE trial results By Investing.com - Investing.com South Africa
Merit Medical (MMSI) Unveils Promising WAVE Trial Results at Symposium | MMSI Stock News - GuruFocus
Merit Medical reports positive WAVE trial results - Investing.com
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial | MMSI Stock News - GuruFocus
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial - The Manila Times
Merit Medical's Breakthrough WRAPSODY Device Exceeds Performance Goals in Major Clinical Trial - Stock Titan
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Learn to Evaluate (MMSI) using the Charts - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Strong Quarterly Results Lifted Merit Medical Systems (MMSI) in Q1 - Insider Monkey
Merit Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Merit Medical (MMSI) Price Target Slashed Amid Revised Earnings Guidance | MMSI Stock News - GuruFocus
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Merit Medical stock target cut to $100 at Needham, retains Buy - Investing.com Nigeria
Merit Medical’s revenue up 9.8% to USD 355.4M in Q1 2025 - Medical Buyer
Merit Medical stock target cut to $100 at Needham, retains Buy By Investing.com - Investing.com South Africa
The Analyst Verdict: Merit Medical Systems In The Eyes Of 17 Experts - Benzinga
Merit Medical (MMSI) Faces Tariff Challenges Amid Margin Expansi - GuruFocus
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up - Yahoo Finance
Merit Medical outlines 2025 revenue growth of up to 10.2% despite tariff challenges - MSN
Merit Medical (MMSI) Target Price Adjusted Amid Tariff Concerns - GuruFocus
Merit Medical (MMSI) Maintains Outperform Rating Despite Adjusted Price Target | MMSI Stock News - GuruFocus
Merit Medical (MMSI) Price Target Cut by Wells Fargo Despite Str - GuruFocus
Merit Medical (MMSI) Price Target Revised by Piper Sandler to $1 - GuruFocus
Decoding Merit Medical Systems Inc (MMSI): A Strategic SWOT Insi - GuruFocus
Merit Medical (MMSI) Reports Strong Q1 2025 Results and Projects Robust Growth - GuruFocus
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance - The Manila Times
Merit Medical Q1 2025 slides: Strong revenue growth overshadowed by lowered EPS guidance - Investing.com South Africa
Merit Medical: Q1 Earnings Snapshot - CTPost
Merit Medical Reports Strong Q1 2025 Results - TipRanks
Earnings call transcript: Merit Medical Q1 2025 beats earnings forecast - Investing.com
Earnings call transcript: Merit Medical Q1 2025 beats earnings forecast By Investing.com - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):